STAHLBERG JAN
SEC CIK 1983161 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | 10% | 7.06M | $14.36M | — | 3 | 2024-06-28 | 2025-08-13 |
Most active insiders at DMAC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TRILL AB | 10% | $7.63M | — |
| 2 | Semba Charles Pauling | Dir | — | — |
| 3 | Pauls Dietrich John | Pres, CEO, Dir | — | — |
| 4 | Parsons James T. | Dir | — | — |
| 5 | Giuffre Randall Michael | Dir | — | — |
STAHLBERG JAN made no open-market trades at DMAC in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-09-04 | 2025-08-13+ | DMAC | DiaMedica Therapeutics Inc. | STAHLBERG JAN | 10% | P - Purchase | $5.96 | +1.00M | 7.06M | +17% | +$5.96M |
| I | 2025-07-25 | 2025-07-23 | DMAC | DiaMedica Therapeutics Inc. | STAHLBERG JAN | 10% | P - Purchase | $3.50 | +1.54M | 6.76M | +30% | +$5.40M |
| I | 2024-07-01 | 2024-06-28 | DMAC | DiaMedica Therapeutics Inc. | STAHLBERG JAN | 10% | P - Purchase | $2.50 | +1.20M | 5.22M | +30% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations